Global Patent Index - EP 1075275 A1

EP 1075275 A1 2001-02-14 - USE OF INTERLEUKIN-18 AS VACCINE ADJUVANT

Title (en)

USE OF INTERLEUKIN-18 AS VACCINE ADJUVANT

Title (de)

ERWENDUNG VON IL-19 ALS IMPSTOFFADJUVANS

Title (fr)

EMPLOI DE L'INTERLEUKINE 18 COMME PRODUIT D'ADDITION POUR VACCIN

Publication

EP 1075275 A1 (EN)

Application

EP 99920854 A

Priority

  • EP 99920854 A
  • EP 9903098 W
  • EP 98201451 A

Abstract (en)

[origin: WO9956775A1] The present invention relates to the use of interleukin-18 (IL-18) as a vaccine adjuvant, adjuvant compositions and vaccines comprising said IL-18, and various recombinant IL-18 to be used in said compositions and vaccines.

IPC 1-7 (main, further and additional classification)

A61K 39/39; A61K 48/00; C07K 14/54; C12N 15/24

IPC 8 full level (invention and additional information)

C12N 15/09 (2006.01); A61K 39/39 (2006.01); A61K 48/00 (2006.01); A61P 37/04 (2006.01); C07K 14/54 (2006.01); C12N 15/24 (2006.01); A61K 39/00 (2006.01)

CPC (invention and additional information)

C07K 14/54 (2013.01); A61K 39/39 (2013.01); A61K 39/00 (2013.01); A61K 48/00 (2013.01); A61K 2039/51 (2013.01); A61K 2039/55527 (2013.01)

Citation (search report)

See references of WO 9956775A1

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

EPO simple patent family

WO 9956775 A1 19991111; AU 3827699 A 19991123; CA 2328059 A1 19991111; EP 1075275 A1 20010214; JP 2002513547 A 20020514

INPADOC legal status


2002-10-09 [18W] WITHDRAWN

- Date of withdrawal: 20020814

2001-10-24 [17Q] FIRST EXAMINATION REPORT

- Effective date: 20010911

2001-02-14 [17P] REQUEST FOR EXAMINATION FILED

- Effective date: 20001207

2001-02-14 [AK] DESIGNATED CONTRACTING STATES:

- Kind Code of Ref Document: A1

- Designated State(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE